Atovaquone how supplied

Revision as of 01:30, 7 January 2014 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Atovaquone
MEPRON® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied

MEPRON Suspension (bright yellow, citrus flavored) containing 750 mg atovaquone in each teaspoonful (5 mL).

Bottle of 210 mL with child-resistant cap (NDC 0173-0665-18).

Store at 15° to 25°C (59° to 77°F). DO NOT FREEZE. Dispense in tight container as defined in USP.

5-mL child-resistant foil pouch - unit dose pack of 42 (NDC 0173-0547-00).

Store at 15° to 25°C (59° to 77°F). DO NOT FREEZE.[1]

References

  1. "MEPRON (ATOVAQUONE) SUSPENSION [GLAXOSMITHKLINE LLC]".

Adapted from the FDA Package Insert.